From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bonus Bearcast for Paul Scott - this is why moral journalists break news of placings - ref Cyan Scoop

By Tom Winnifrith, The Sheriff of AIM | Wednesday 25 May 2016


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Paul Scott is slating me for breaking news of the Cyan (CYAN) placing which the company has now confirmed in a grudging sort of manner. I examine why Paul is upset but explain why his argument is flawed and why he needs to direct his ire at the company not at me. Ever since there have been financial journalists our job has been to break stories of placings, bids and profits warnings. I explain why that is the moral thing to do and exactly why it was the moral thing to do to break the Cyan placing today. I've been breaking such stories as a financial journalist for 25 years. I am bloody good at it and so have no plans to stop. It is one of the few things I do which I can say, without doubt, is morally right. My snake encounter article, I mention in the podcast, is HERE


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:30:46